Education
About Us
Working with TipRanks
Follow Us
Sequent Scientific Limited (IN:SEQUENT)
:SEQUENT
RESEARCH TOOLSreports
Total Valuation
Sequent Scientific Limited has a market cap or net worth of ₹43.55B. The enterprise value is ₹37.47B.
Market Cap₹43.55B
Enterprise Value₹37.47B
Share Statistics
Sequent Scientific Limited has 250,334,990 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding250,334,990
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sequent Scientific Limited’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 26.11%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)26.11%
Return on Capital Employed (ROCE)0.42
Revenue Per Employee12.98M
Profits Per Employee183.10K
Employee Count1,195
Asset Turnover0.97
Inventory Turnover2.11
Valuation Ratios
The current PE Ratio of Sequent Scientific Limited is 146.4. Sequent Scientific Limited’s PEG ratio is ―.
PE Ratio146.4
PS Ratio―
PB Ratio―
Price to Fair Value4.96
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Sequent Scientific Limited had revenue of 15.51B and earned 218.80M in profits. Earnings per share was 0.88.
Revenue15.51B
Gross Profit7.40B
Operating Income4.58B
Pretax Income443.10M
Net Income218.80M
EBITDA1.59B
Earnings Per Share (EPS)0.88
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Sequent Scientific Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.27
52-Week Price Change8.92%
50-Day Moving Average181.89
200-Day Moving Average173.31
Relative Strength Index (RSI)44.96
Average Volume (3m)36.55K
Important Dates
Sequent Scientific Limited upcoming earnings date is Nov 10, 2025, TBA (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend DateSep 08, 2021
Financial Position
Sequent Scientific Limited as a current ratio of 1.73, with Debt / Equity ratio of 68.31%
Current Ratio1.73
Quick Ratio0.97
Debt to Market Cap0.13
Net Debt to EBITDA2.59
Interest Coverage Ratio7.55
Taxes
In the past 12 months, Sequent Scientific Limited has paid 120.50M in taxes.
Income Tax120.50M
Effective Tax Rate0.27
Enterprise Valuation
Sequent Scientific Limited EV to EBITDA ratio is 24.60, with an EV/FCF ratio of 88.28.
EV to Sales2.52
EV to EBITDA24.60
EV to Free Cash Flow88.28
EV to Operating Cash Flow46.88
Balance Sheet
Sequent Scientific Limited has ₹691.40M in cash and marketable securities with ₹4.81B in debt, giving a net cash position of ₹4.12B billion.
Cash & Marketable Securities₹691.40M
Total Debt₹4.81B
Net Cash₹4.12B
Net Cash Per Share₹16.46
Tangible Book Value Per Share₹18.19
Margins
Gross margin is 47.67%, with operating margin of 29.55%, and net profit margin of 1.41%.
Gross Margin47.67%
Operating Margin29.55%
Pretax Margin2.86%
Net Profit Margin1.41%
EBITDA Margin10.24%
EBIT Margin5.96%
Analyst Forecast
The average price target for Sequent Scientific Limited is ₹176.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹176.00
Price Target Upside1.18% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast12.33%
EPS Growth Forecast439.46%